Raj Denhoy
Stock Analyst at Jefferies
(1.94)
# 1,713
Out of 4,479 analysts
15
Total ratings
75%
Success rate
26.08%
Average return
Main Sectors:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $103.20 | +40.50% | 3 | Oct 21, 2021 | |
| EW Edwards Lifesciences | Maintains: Buy | n/a | $91.23 | - | 1 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | n/a | $73.53 | - | 1 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $8.58 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | n/a | $112.49 | - | 1 | Aug 2, 2018 | |
| AXGN AxoGen | Initiates: Buy | n/a | $7.52 | - | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | n/a | $211.25 | - | 2 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | n/a | $52.89 | - | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | n/a | $78.50 | - | 1 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | n/a | $197.19 | - | 1 | Nov 3, 2017 |
Abbott Laboratories
Oct 21, 2021
Maintains: Buy
Price Target: $135 → $145
Current: $103.20
Upside: +40.50%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: n/a
Current: $91.23
Upside: -
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: n/a
Current: $73.53
Upside: -
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $8.58
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: n/a
Current: $112.49
Upside: -
AxoGen
Nov 30, 2017
Initiates: Buy
Price Target: n/a
Current: $7.52
Upside: -
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: n/a
Current: $211.25
Upside: -
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: n/a
Current: $52.89
Upside: -
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: n/a
Current: $78.50
Upside: -
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: n/a
Current: $197.19
Upside: -